$CTRV Taking a broader look brokerage firms’ analysts on the street with an expectant view have Contravir Pharmaceut (NASDAQ:CTRV) high price target of $4 and with a conservative view have low price target of $4. CTRV
Maxim Group “Initiates Coverage on” Contravir Pharmaceut (NASDAQ:CTRV) in a research note issued to investors on 5/06/16 to Buy.
Contravir Pharmaceut (NASDAQ:CTRV) shares traded 16.4% up during most recent session to reach at the closing price of $0.29.Analysts Alert: Contravir Pharmaceut (CTRV) ExpertGazette - 2d ago
Contravir Pharmaceut (NASDAQ:CTRV) shares traded 16.4% up during most recent session to reach at the closing price of $0.29.